implantable cardioverter defibrillator
Report ID: SQMIG35A2207 | Region: Global | Published Date: December, 2022 | Pages: 224 | Tables: 64 | Figures: 75
Global Cardioverter Defibrillator Device market size was valued at USD 11.19 billion in 2021 and is poised to grow to USD 20.8 billion by 2030, growing at a CAGR of 7.2% in the forecast period (2023-2030).
Cardioverter defibrillator is the electronic device that is used in the treatment of sudden cardiac arrest as well as arrhythmia. The global market growth is attributed to increasing product development, growing awareness among the general public, increasing prevalence of sudden cardiac arrest, and initiatives by governments and healthcare organizations. Smoking, sedentary lifestyle, and obesity are the factors responsible for cardiac arrest. In emerging countries such as China, India, and Brazil there is an increasing prevalence of cardiac arrest which is expected to propel the market growth.
US Cardioverter Defibrillator Device Market is poised to grow at a sustainable CAGR for the next forecast year.
Largest Segment
implantable cardioverter defibrillator
Fastest Growth
external cardioverter defibrillators
To get more reports on the above market click here to Buy The Report
The cardioverter defibrillator devices market is segmented into type, end user, and region. Based on type, the global market is segmented into implantable cardioverter defibrillators and external cardioverter defibrillators. Based on end-user, the global market is segmented into hospitals, pre-hospitals, public access market, alternative care, and home. By region, the market is segmented into North America, Latin America, Europe, Asia Pacific, and MEA.
Analysis by Type
Based on type, the global market is segmented into implantable cardioverter defibrillator and external cardioverter defibrillator. Implantable cardioverter defibrillator is further segmented into transvenous implantable cardioverter defibrillator (T-ICDs), subcutaneous implantable cardioverter defibrillator (S-ICDs), and cardiac resynchronization therapy defibrillator (CRT-D). External cardioverter defibrillator is further segmented into manual external defibrillator, automated external defibrillator (AEDs), and wearable cardioverter defibrillator (WCDs).
The implantable defibrillator segment is expected to dominate the global market over the forecast period due to increasing geriatric population, emergence of new technologies, and increasing adoption of S-ICDs, and increasing prevalence of sudden cardiac arrest.
The external defibrillator is expected to have considerable growth over the forecast period due to advancement in technology in the healthcare sector and increasing adoption of external defibrillators installation.
Analysis by End-user
Hospital segment is expected to dominate the global market. The market growth is attributed to the increasing number of cardiac patients admitted in hospitals and the surgeries performed in hospital settings. In hospitals, for treating cardiac arrest patients both ICDs and external defibrillators are used increasingly.
Alternative care segment is expected to have considerable growth during the forecast period due to rising demand for early diagnosis initiatives taken by government or private organizations for development of alternative care.
To get detailed analysis on other segments, Request For Sample Report
North America is expected to hold the largest market share during the forecast period due to initiatives taken by key players, favorable regulations, and advanced technological facilities in the U.S and Canada.
In 2020, Bostan Scientific distributed about 33,000 CRT-Ds line up that include Resonate, Autogen, Dynagen, Incepta, and Cognis devices worldwide. Out of these, 16,500 were registered in the U.S alone indicating high adoption rate.
Asia Pacific region is projected to expand at the fastest CAGR during the forecast period. The market growth is attributed to the developing healthcare infrastructure, high patient population, and prevalence of cardiac diseases. regional growth is fast due to the Japanese market having high penetration of defibrillators and supportive policies.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Cardioverter Defibrillator Device Market Drivers
Increasing Technological Advancement in defibrillator
● Defibrillators have improved in terms of cost, size reduction, and ease of operation. The advancement in technology is as follows- automated external defibrillator (AED) and implantable cardioverter defibrillator (ICD). These devices are effective in controlling cardiac attack conditions. Due to technological advancements in defibrillators, the operating defibrillator has become easy for an observer post-induction of proper training.
● The growing prevalence of cardiovascular diseases such as arrhythmias and heart failure are expected to contribute to the market demand. According to WHO, cardiovascular diseases are leading causes for global deaths.
Restraints
High Costs of Defibrillators and Lack of Skilled Professionals to Impede the Market Growth
● Cardioverter defibrillators are highly expensive and cost barriers can occur for patients belonging to low-income group. Also, with a limited healthcare budget, these devices are likely to witness a low rate of adoption in the coming years.
● Lack of skilled professionals such as electrophysiologists, cardiologists, and cardiac surgeons are likely to create a reduce adoption of heart defibrillators
Speak to one of our ABIRAW analyst for your custom requirements before the purchase of this report
Global cardioverter defibrillator devices market is highly competitive. Implantable cardioverter defibrillator key market players are Medtronic PLC, Abbott Laboratories, and Boston Scientific Corporation. Koninklijke Philips N.V., Cardiac Science Corporation, and Zoll Medical Corporation are leading the external defibrillator market. Key players undergo mergers and acquisitions to produce innovative products. They also focus on strengthening their position in the global market.
Top Company Profiles
● Medtronic PLC
● Abbott Laboratories
● Boston Scientific Corporation
● BIOTRONIK SE & Co. KG
● LivaNova PLC
● Stryker Corporation
● Koninklijke Philip N.V.
● Cardiac Science Corporation
● Zoll medical corporation
● Nihon Kohden Corporation
● Progetti Srl
● Fukuda Denshi Co.
● Schiller AG
● In June 2020, ZOLL Medical Corporation, an Asahi Kasei Group Company received premarket approval for its ZOLL AED 3 defibrillator with enhanced real CPR help, integrated child rescue, and wireless connectivity.
● In 2020, the US FDA approved leadless defibrillator for heart patients. This device can be implanted directly into the heart and does not require any non-invasive surgeries.
● Smart Pacemaker to Elevate Market Demand: Smart pacemaker is a device that can detect even the smallest irregularity in the functioning of the heart. Smart pacemakers rectify the abnormalities in the heart and re-establish normal body function. It also alerts the patients as well as physicians about the patient's cardiac health. This feature of the smart maker helps to decrease the mortality rate.
● Increasing emphasis on product customization: With technological advancements and growing demand for customization, manufacturers are offering innovative products that can be customized according to patient needs
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates, and Analyses the Data collected utilizing Primary Exploratory Research backed by robust Secondary Desk research.
According to the global cardioverter defibrillator devices market analysis, the market growth is attributed to increasing sudden cardiac arrest patients, and government investment in R&D to produce innovative products. The implantable cardioverter defibrillator segment dominates the market because it is widely used by the healthcare sector. North America leads the global market due to the presence of technological advancement.
Report Metric | Details |
---|---|
Base year | the |
Segments covered |
|
Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
For the Global Cardioverter Defibrillator Device Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Global Cardioverter Defibrillator Device Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Global Cardioverter Defibrillator Device Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Global Cardioverter Defibrillator Device Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
Our industry expert will work with you to provide you with customized data in a short amount of time.
SPEAK TO AN ANALYSTGet lifetime access to our reports
Basic Plan $5,000 Team Plan $10,000 SUBSCRIBE NOWCardioverter Defibrillator Device Market size was valued at USD 11.19 billion in 2021 and is poised to grow from USD 12 billion in 2022 to USD 20.8 billion by 2030, growing at a CAGR of 7.2% in the forecast period (2023-2030).
Global cardioverter defibrillator devices market is highly competitive. Implantable cardioverter defibrillator key market players are Medtronic PLC, Abbott Laboratories, and Boston Scientific Corporation. Koninklijke Philips N.V., Cardiac Science Corporation, and Zoll Medical Corporation are leading the external defibrillator market. Key players undergo mergers and acquisitions to produce innovative products. They also focus on strengthening their position in the global market. 'Medtronic plc', 'Abbott Laboratories', 'Boston Scientific Corporation', 'Biotronik SE & Co. KG', 'Koninklijke Philips N.V.', 'LivaNova PLC', 'Microport Scientific Corporation', 'Nihon Kohden Corporation', 'Progetti Srl', 'Schiller AG', 'Zoll Medical Corporation (a subsidiary of Asahi Kasei Corporation)', 'Stryker Corporation', 'Defibtech, LLC', 'Cardiac Science Corporation', 'Physio-Control International (a subsidiary of Stryker Corporation)', 'CU Medical Systems, Inc.', 'Fukuda Denshi Co., Ltd.', 'Mindray Medical International Limited', 'Welch Allyn, Inc. (a subsidiary of Hill-Rom Holdings, Inc.)', 'Cardionet (a subsidiary of BioTelemetry, Inc.)'
Defibrillators have improved in terms of cost, size reduction, and ease of operation. The advancement in technology is as follows- automated external defibrillator (AED) and implantable cardioverter defibrillator (ICD). These devices are effective in controlling cardiac attack conditions. Due to technological advancements in defibrillators, the operating defibrillator has become easy for an observer post-induction of proper training. In April 2019, Biotronik, a Medical Device Company launched the Acticor device family of new implantable cardioverter defibrillators and cardiac resynchronization therapy defibrillator (CRT-Ds).
Smart pacemaker is a device that can detect even the smallest irregularity in the functioning of the heart. Smart pacemakers rectify the abnormalities in the heart and reestablish normal body function. It also alerts the patients as well as physicians about the patient's cardiac health. This feature of the smart maker helps to decrease the mortality rate.
North America is expected to hold the largest market share during the forecast period due to initiatives taken by key players, favorable regulations, and advanced technological facilities in the U.S and Canada.
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Product ID: SQMIG35A2207